Sawgrass Asset Management LLC Abb Vie Inc. Transaction History

Sawgrass Asset Management LLC

$920 Million
Q2 2024

A detailed history of Sawgrass Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 89,201 shares of ABBV stock, worth $15.4 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

89,201

Previous 89,755 0.62%

Holding current value

$15.4 Million

Previous $16.3 Million 6.39%

% of portfolio

1.66%

Previous 1.81%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$154.79 - $180.76 $85,753 - $100,141	-554 Reduced 0.62%	89,201 $15.3 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $638,161 - $727,125	-3,993 Reduced 4.26%	89,755 $16.3 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $2.63 Million - $2.97 Million	19,136 Added 25.65%	93,748 $14.5 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $721,786 - $835,573	-5,403 Reduced 6.75%	74,612 $11.1 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $8.49 Million - $10.6 Million	-64,091 Reduced 44.47%	80,015 $10.8 Million

Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $540,696 - $622,693	-3,739 Reduced 2.53%	144,106 $23 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $432,633 - $518,841	-3,128 Reduced 2.07%	147,845 $23.9 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $2.2 Million - $2.53 Million	16,413 Added 12.2%	150,973 $20.3 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $11.9 Million - $15.2 Million	-86,782 Reduced 39.21%	134,560 $20.6 Million
Q1 2022 May 18, 2022	BUY	$131.98 - $163.75 $29.2 Million - $36.2 Million	221,342 New	221,342 $35.9 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $23.8 Million - $30.1 Million	-221,192 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $4.15 Million - $4.71 Million	-38,965 Reduced 14.98%	221,192 $23.9 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $8.6 Million - $9.59 Million	-81,785 Reduced 23.92%	260,157 $29.3 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $3.91 Million - $4.3 Million	38,222 Added 12.58%	341,942 $37 Million
Q4 2020 Jan 22, 2021	SELL	$80.49 - $108.67 $465,071 - $627,895	-5,778 Reduced 1.87%	303,720 $32.5 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $6.65 Million - $7.8 Million	77,352 Added 33.32%	309,498 $27.1 Million
Q2 2020 Jul 27, 2020	SELL	$73.37 - $98.18 $1.48 Million - $1.98 Million	-20,189 Reduced 8.0%	232,146 $22.8 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $2.84 Million - $4.31 Million	-44,054 Reduced 14.86%	252,335 $19.2 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $374,787 - $468,939	-5,196 Reduced 1.72%	296,389 $26.2 Million
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $10.4 Million - $12.5 Million	-165,727 Reduced 35.46%	301,585 $22.8 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $1.7 Million - $2.17 Million	25,800 Added 5.84%	467,312 $34 Million
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $2.5 Million - $2.95 Million	32,458 Added 7.93%	441,512 $35.6 Million
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $2.19 Million - $2.7 Million	28,134 Added 7.39%	409,054 $37.7 Million
Q3 2018 Nov 19, 2018	BUY	$88.91 - $98.84 $32.1 Million - $35.6 Million	360,671 Added 1781.18%	380,920 $36 Million
Q2 2018 Jul 26, 2018	SELL	$89.78 - $106.23 $26.9 Million - $31.9 Million	-300,000 Reduced 93.68%	20,249 $29.7 Million
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $810,892 - $959,469	9,032 Added 2.9%	320,249 $29.7 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $6.73 Million - $9.01 Million	-73,090 Reduced 19.02%	311,217 $29.5 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $18.6 Million - $20.4 Million	-208,100 Reduced 35.13%	384,307 $37.2 Million
Q3 2017 Nov 09, 2017	SELL	$69.85 - $89.22 $6.59 Million - $8.41 Million	-94,275 Reduced 13.73%	592,407 $52.6 Million
Q2 2017 Aug 11, 2017	BUY	N/A	686,682	686,682 $49.8 Million

Others Institutions Holding ABBV

# of Institutions

3,650

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $305B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.

Account

Sawgrass Asset Management LLC Abb Vie Inc. Transaction History